Oncology

Biomarker linked to prognosis in aggressive ovarian cancer

Researchers have identified a protein biomarker expressed on the surface of tumour cells in high-grade serous ovarian cancer, which is the most common and lethal subtype of the disease. According to the Canadian scientists, from institutions including the Princess Margaret Cancer Centre (PMCC) and...

Mediterranean diet could reduce risk of deadly breast cancer

A Mediterranean diet could reduce the risk of a severe form of breast cancer by up to 40 per cent, according to a new study. The scientists involved in the study monitored more than 62,000 women over a period of 20 years in order to work out how their diets could affect their risk of breast cancer...

New vulnerability in aggressive breast cancer provides treatment target

Researchers from the Cancer Center at Beth Israel Deaconess Medical Center (BIDMC), Massachusetts, US, have discovered a vulnerability that could provide a new strategy to combat triple-negative breast cancer (TNBC). Currently, physicians currently have no targeted treatment options available for...

Poor adolescent diet associated with premenopausal breast cancer

Research has shown that women who consumed a diet as adolescents or young adults associated with chronic inflammation had a higher risk for premenopausal breast cancer. A diet low in vegetables and high in sugar-sweetened and diet soft drinks, refined sugars and carbohydrates, red and processed...

Blood tests ‘can find ovarian cancer early’

New research has shown that screening women at high risk of ovarian cancer every four months by blood tests may reduce the likelihood of them being diagnosed with advanced ovarian cancer. The multi-institute United Kingdom Familial Ovarian Cancer Screening Study is a long-term study looking at...

Flowers used to remind women to attend cervical cancer screening

Health campaigners have set up a huge wall of flowers in the city centre of Glasgow, UK, in an attempt to get more women thinking and talking about cervical cancer screening. Campaigners are also handing out one thousand flowers to women in the city as a reminder to attend their next cervical...

Biennial mammograms best after age 50

Screening for breast cancer every two years appears just as beneficial as yearly mammograms for women ages 50 to 74, with significantly fewer false positives, according to new research. The study, conducted by the University of California - San Francisco (UCSF), US, found that this was true even...

New technique ‘could reduce breast cancer screening recall rate’

A new breast cancer detection technique has the potential to reduce the rate at which women are called back for further examinations, according to a new study. In 2011, the US Food and Drug Administration (FDA) approved digital breast tomosynthesis (DBT) for use with full-field digital mammography...

New trial offers combination therapy to combat ovarian cancer

A new clinical trial is offering combination therapy to directly kill ovarian cancer cells and teach the immune system to prevent them returning. The clinical trial is focusing on women whose ovarian cancer results from mutated BRCA genes. It combines one drug that kills the ovarian cancer cells...

NICE recommends Intrabeam radiotherapy for breast cancer patients

The UK’s National Institute for Health and Care Excellence (NICE) has published guidance recommending the “controlled use of targeted breast cancer radiotherapy treatment alongside further research”. NICE said that it has recommended the Intrabeam Radiotherapy System for people...